Exosomal miRNA-21 derived from umbilical cord mesenchymal stem cells inhibits microglial overactivation to counteract nerve damage
- PMID: 39196412
- DOI: 10.1007/s11033-024-09878-8
Exosomal miRNA-21 derived from umbilical cord mesenchymal stem cells inhibits microglial overactivation to counteract nerve damage
Abstract
Background: Traumatic brain injury (TBI) is a major cause of neurological disability, and current treatments have limited effectiveness. Recent studies have emphasized the potential of exosomes derived from umbilical cord mesenchymal stem cells (UC-MSCs-Exo) in TBI treatment, but the molecular mechanisms underlying their therapeutic effects are not fully understood.
Methods and results: In this study, UC-MSCs-Exo was isolated using ultracentrifugation and intraventricularly injected to TBI rat model. The neurofunctional motor function of the rats was evaluated using the modified neurological severity score (mNSS), and the activation of microglia was assessed through immunofluorescence detection of IBA1 expression levels. Additionally, we established an in vitro neuroinflammatory model using BV2 microglia to investigate the effects of UC-MSCs-Exo and miRNA-21. Our findings indicate that UC-MSCs-Exo promote neurological recovery in TBI rats and inhibit excessive microglia activation. Furthermore, UC-MSCs-Exo highly expresses miRNA-21 and inhibited the proliferation, migration, and release of inflammatory mediators of BV2 microglia by transporting miRNA-21.
Conclusions: The present study suggests that the promotion of neurological recovery in TBI rats by UC-MSCs-Exo may be attributed to the inhibition of excessive microglia activation through miRNA-21.
Keywords: Mesenchymal stem cell exosomes; Microglia; Nerve damage; Traumatic brain injury; miRNA.
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
Human umbilical cord mesenchymal stem cell-derived exosomes promote neurological function recovery in rat after traumatic brain injury by inhibiting the activation of microglia and astrocyte.Regen Ther. 2022 Aug 28;21:282-287. doi: 10.1016/j.reth.2022.07.005. eCollection 2022 Dec. Regen Ther. 2022. PMID: 36092501 Free PMC article.
-
Protective effect of BMSCs-derived exosomes mediated by BDNF on TBI via miR-216a-5p.Med Sci Monit. 2020 Mar 9;26:e920855. doi: 10.12659/MSM.920855. Med Sci Monit. 2020. PMID: 32150531 Free PMC article.
-
The Promising Effects of Transplanted Umbilical Cord Mesenchymal Stem Cells on the Treatment in Traumatic Brain Injury.J Craniofac Surg. 2018 Oct;29(7):1689-1692. doi: 10.1097/SCS.0000000000005042. J Craniofac Surg. 2018. PMID: 30234712 Free PMC article.
-
Can Mesenchymal Stem Cells Act Multipotential in Traumatic Brain Injury?J Mol Neurosci. 2020 May;70(5):677-688. doi: 10.1007/s12031-019-01475-w. Epub 2020 Jan 2. J Mol Neurosci. 2020. PMID: 31897971 Review.
-
New Therapeutic Strategies for the Inflammatory Rheumatoid Arthritis Disease: Emphasizing Mesenchymal Stem Cells and Associated exo-miRNA or exo-lncRNA.Cell Biochem Biophys. 2024 Sep;82(3):1599-1611. doi: 10.1007/s12013-024-01316-7. Epub 2024 May 31. Cell Biochem Biophys. 2024. PMID: 38822204 Review.
References
-
- Galgano M, Toshkezi G, Qiu X et al (2017) Traumatic brain injury: current treatment strategies and future endeavors. Cell Transpl 26:1118–1130. https://doi.org/10.1177/0963689717714102 - DOI
-
- Stocchetti N, Carbonara M, Citerio G et al (2017) Severe traumatic brain injury: targeted management in the intensive care unit. Lancet Neurol 16:452–464. https://doi.org/10.1016/S1474-4422(17)30118-7 - DOI - PubMed
-
- Brett BL, Gardner RC, Godbout J et al (2022) Traumatic brain injury and risk of neurodegenerative disorder. Biol Psychiatry 91:498–507. https://doi.org/10.1016/j.biopsych.2021.05.025 - DOI - PubMed
-
- Witcher KG, Bray CE, Chunchai T et al (2021) Traumatic brain injury causes chronic cortical inflammation and neuronal dysfunction mediated by microglia. J Neurosci 41:1597–1616. https://doi.org/10.1523/JNEUROSCI.2469-20.2020 - DOI - PubMed - PMC
-
- Wang D, Zhang S, Ge X et al (2022) Mesenchymal stromal cell treatment attenuates repetitive mild traumatic brain injury-induced persistent cognitive deficits via suppressing ferroptosis. J Neuroinflammation 19:185. https://doi.org/10.1186/s12974-022-02550-7 - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical